Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing... Show more
AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical devices, operating in two main segments: Electronic Instruments (EI) and Electromechanical (EMG). The company serves diverse end markets including aerospace, medical, transportation, and industrial automation. Its business model emphasizes high-margin, niche products, strategic acquisitions, and operational excellence, driving consistent organic growth and margin expansion. With a strong competitive position in precision instrumentation, AMETEK's fundamentals—record backlog and robust free cash flow—underpin its resilience, though recent stock price movement reflects broader market dynamics rather than company-specific weaknesses.
Over the last 30 days, AME stock fell -11.4%, closing at $209.24 from around $236 approximately one month ago. The decline was volatile, with a peak near $242 early in March followed by a steady pullback, trading in a range-bound fashion amid higher volume on down days.
For the past quarter, the stock edged up +0.3%, starting near $208 and reaching an all-time high of $242 before retracing. Movement was trend-driven upward initially on positive momentum, then range-bound with increased volatility in late March.
The 30-day decline stemmed primarily from profit-taking after the stock hit record highs near $242, coinciding with broader industrials weakness. Analyst actions played a role, including an Oppenheimer downgrade in late January citing valuation after appreciation, with shares trading at 26x forward earnings. Insider sales, such as a director's transaction noted in late March, added to sentiment pressure. Macro factors like persistent inflation concerns and sector rotation out of cyclicals amplified the move, despite no negative company news. Trading volume spiked on down days, indicating institutional repositioning.
The quarterly uptick was fueled by stellar Q4 2025 results announced February 3: record $2.0 billion sales (+13%), adjusted EPS $2.01 (beat estimates), and operating margins at 26.2%. Orders surged 18% with a $3.58 billion backlog signaling sustained demand. Multiple analyst upgrades post-earnings, including price target hikes to $265 by Truist and $260 by TD Cowen, drove the rally to all-time highs. Acquisitions like LKC Technologies bolstered growth narrative. However, rising rates and industrial slowdown fears capped gains, leading to consolidation. Institutional buying supported the modest net positive amid macro headwinds.
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI trading bots from hundreds available, each scanning thousands of tickers across strategies like trend-following, mean reversion, and momentum plays. These curated bots highlight real-time leaders based on metrics such as win rate, Sharpe ratio, and risk-adjusted returns over various timeframes from intraday to long-term. While past performance varies and no bot guarantees future results, the section offers transparency into algorithmic edge. Explore the page to identify bots aligning with your risk tolerance and market view, potentially enhancing your trading toolkit.
Investors should monitor Q1 2026 earnings for progress on $1.91 billion revenue and $1.85-$1.90 EPS guidance, alongside updates on the $3.58 billion backlog. Industry trends in aerospace and automation demand remain key, as does M&A pipeline including Faro integration. Macro environment—interest rates, industrial PMI, and inflation—could sway sentiment. Upcoming dividend hikes and analyst revisions post-quarterly results are catalysts, while risks include supply chain issues or sector rotation. Strategic developments like new product launches in EI segment warrant attention.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
The Moving Average Convergence Divergence (MACD) for AME turned positive on April 01, 2026. Looking at past instances where AME's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 01, 2026. You may want to consider a long position or call options on AME as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
AME moved above its 50-day moving average on April 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AME crossed bullishly above the 50-day moving average on April 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AME advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AME declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AME broke above its upper Bollinger Band on April 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AME entered a downward trend on April 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. AME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.105) is normal, around the industry mean (4.677). P/E Ratio (37.003) is within average values for comparable stocks, (54.485). Projected Growth (PEG Ratio) (2.968) is also within normal values, averaging (2.431). Dividend Yield (0.005) settles around the average of (0.024) among similar stocks. P/S Ratio (7.402) is also within normal values, averaging (58.121).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of electronic instruments and electromechanical devices
Industry IndustrialMachinery